Robbins Andrew R 4
4 · Cogent Biosciences, Inc. · Filed Jan 25, 2024
Insider Transaction Report
Form 4
Robbins Andrews R
DirectorPresident and CEO
Transactions
- Award
Stock Option (Right to Buy)
2024-01-23+1,100,000→ 1,100,000 totalExercise: $4.63Exp: 2034-01-23→ Common Stock (1,100,000 underlying)
Footnotes (1)
- [F1]This stock option shall vest in equal monthly installments over a four year period.